BeOne Medicines AG (ONC) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDT
Company Participants
Daniel Maller - Vice President of Investor Relations
John Oyler - Co-Founder, Executive Chairman & CEO
Aaron Rosenberg - Chief Financial Officer
Wang Lai - President and Global Head of Research & Development
Amit Agarwal
Matthew Shaulis
Xiaobin Wu
Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors
Conference Call Participants
Yigal Nochomovitz - Citigroup Inc., Research Division
Kalpit Patel - Wolfe Research, LLC
Jessica Fye - JPMorgan Chase & Co, Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Ziyi Chen - Goldman Sachs Group, Inc., Research Division
Gregory Renza - Truist Securities, Inc., Research Division
Michael Schmidt - Guggenheim Securities, LLC, Research Division
Reni Benjamin - Citizens JMP Securities, LLC, Research Division
Yaron Werber - TD Cowen, Research Division
Sean Laaman - Morgan Stanley, Research Division
Presentation
Operator
Good day, everyone. Welcome to BeOne Medicines Q1 2026 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over to the company.
Daniel Maller
Vice President of Investor Relations
Hello and welcome. Thanks for joining us today. I'm Dan Maller, Head of Investor Relations at BeOne Medicines. Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the Investor Relations section of our website ir.beonemedicines.com.
I would like to remind all participants that during this call, we may make forward-looking statements regarding, among other things, the company's future prospects and business strategy. Actual results may differ materially from those indicated in the forward-looking statements as a result of various factors, including those risks discussed in our most periodic -- recent periodic report filed with the SEC.
Please also carefully review the forward-looking statements disclaimer in the slide deck that accompanies this presentation. Reconciliations between GAAP and non-GAAP financial measures
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。